Correlation Between Onxeo SA and AURUBIS AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Onxeo SA and AURUBIS AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onxeo SA and AURUBIS AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onxeo SA and AURUBIS AG UNSPADR, you can compare the effects of market volatilities on Onxeo SA and AURUBIS AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onxeo SA with a short position of AURUBIS AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onxeo SA and AURUBIS AG.

Diversification Opportunities for Onxeo SA and AURUBIS AG

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Onxeo and AURUBIS is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Onxeo SA and AURUBIS AG UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AURUBIS AG UNSPADR and Onxeo SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onxeo SA are associated (or correlated) with AURUBIS AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AURUBIS AG UNSPADR has no effect on the direction of Onxeo SA i.e., Onxeo SA and AURUBIS AG go up and down completely randomly.

Pair Corralation between Onxeo SA and AURUBIS AG

Assuming the 90 days horizon Onxeo SA is expected to under-perform the AURUBIS AG. In addition to that, Onxeo SA is 1.85 times more volatile than AURUBIS AG UNSPADR. It trades about -0.07 of its total potential returns per unit of risk. AURUBIS AG UNSPADR is currently generating about -0.01 per unit of volatility. If you would invest  4,100  in AURUBIS AG UNSPADR on September 13, 2024 and sell it today you would lose (60.00) from holding AURUBIS AG UNSPADR or give up 1.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Onxeo SA  vs.  AURUBIS AG UNSPADR

 Performance 
       Timeline  
Onxeo SA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Onxeo SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Onxeo SA reported solid returns over the last few months and may actually be approaching a breakup point.
AURUBIS AG UNSPADR 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AURUBIS AG UNSPADR are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, AURUBIS AG reported solid returns over the last few months and may actually be approaching a breakup point.

Onxeo SA and AURUBIS AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Onxeo SA and AURUBIS AG

The main advantage of trading using opposite Onxeo SA and AURUBIS AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onxeo SA position performs unexpectedly, AURUBIS AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AURUBIS AG will offset losses from the drop in AURUBIS AG's long position.
The idea behind Onxeo SA and AURUBIS AG UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments